Back to User profile » Dr Hidekazu Nakanishi
Papers published by Dr Hidekazu Nakanishi:
Four Cases with FUS/CHOP Fusion Gene Products Positive Myxoid Liposarcoma Responding Effectively to Trabectedin Monotherapy
Kirishi H, Yamane H, Ochi N, Sunada Y, Mimura A, Kosaka Y, Ichiyama N, Kawahara T, Nagasaki Y, Nakanishi H, Kunisada T, Takigawa N
OncoTargets and Therapy 2024, 17:1059-1067
Published Date: 16 November 2024
IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy
Taoka M, Ochi N, Mimura A, Ichiyama N, Nagasaki Y, Nakagawa N, Nakanishi H, Yamane H, Oshiro Y, Monobe Y, Takigawa N
Therapeutics and Clinical Risk Management 2021, 17:571-575
Published Date: 3 June 2021
Descending necrotizing mediastinitis in a healthy young adult
Ochi N, Wakabayashi T, Urakami A, Yamatsuji T, Ikemoto N, Nagasaki Y, Nakagawa N, Honda Y, Nakanishi H, Yamane H, Monobe Y, Akisada T, Katayama H, Naomoto Y, Takigawa N
Therapeutics and Clinical Risk Management 2018, 14:2013-2017
Published Date: 17 October 2018
Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
Yamane H, Ochi N, Nagasaki Y, Yamagishi T, Honda Y, Nakagawa N, Takeyama M, Nakanishi H, Takigawa N
Therapeutics and Clinical Risk Management 2018, 14:1457-1465
Published Date: 21 August 2018
Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities
Yamane H, Kunisada T, Ozaki T, Ochi N, Honda Y, Nagasaki Y, Nakagawa N, Yamagishi T, Nakanishi H, Takigawa N
Cancer Management and Research 2018, 10:353-359
Published Date: 19 February 2018